There are 805 resources available
67P - Bioplatin, a novel oral platinum-based compound: Potential for cancer prevention and treatment in SCID mice using xenograft models of prostate cancer
Presenter: Yogesh Bendale
Session: Poster Display session
Resources:
Abstract
68P - Patient-reported outcomes (PROs) in Chinese patients with mantle cell lymphoma (MCL) after covalent Bruton’s tyrosine kinase inhibitor (cBTKi) treatment: Post-hoc analysis from a phase II study
Presenter: Yanyan Liu
Session: Poster Display session
Resources:
Abstract
69P - Enhanced efficacy of resveratrol-loaded porous silicon nanocarriers in targeting nucleolin for breast cancer therapy
Presenter: Siuli Shaw
Session: Poster Display session
Resources:
Abstract
70P - Hypofractionated radiotherapy in combination with PD-1 inhibitors, GM-CSF and thymosin α1 in advanced relapsed metastatic solid tumors: An interim analysis of a single-arm phase II multicenter prospective clinical study
Presenter: Jiamin Yu
Session: Poster Display session
Resources:
Abstract
71P - Efficacy of low-dose nivolumab in advanced carcinomas
Presenter: Abhishek Tiwari
Session: Poster Display session
Resources:
Abstract
72TiP - Next-generation T-cell receptor T cell therapy (SCG142) against human papilloma virus (HPV) for patients with recurrent or metastatic HPV16/52-positive carcinomas
Presenter: Hongying Lv
Session: Poster Display session
Resources:
Abstract
75P - Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): An open-label, single-arm, phase II study
Presenter: Zhan Wang
Session: Poster Display session
Resources:
Abstract
76P - Impact of quality of life factors on survival in colorectal cancer patients: A retrospective cohort study
Presenter: Park Daseul
Session: Poster Display session
Resources:
Abstract
77P - Efficacy and safety of iparomlimab and tuvonralimab (QL1706) in untreated metastatic colorectal cancer (mCRC)
Presenter: Jin Li
Session: Poster Display session
Resources:
Abstract
78P - Design and optimization of colorectal cancer neoantigens mRNA vaccines with a naturel TLR-stimulating adjuvant
Presenter: Saber Imani
Session: Poster Display session
Resources:
Abstract